(Q48366250)

11 February 2018

title

Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study (English)

1 reference

11 February 2018

author

Benjamin Becker

1

1 reference

11 February 2018

Jörg Daumann

7

1 reference

11 February 2018

Jörg Daumann

8

1 reference

11 February 2018

Katja Mercer-Chalmers-Bender

object named as

Katja Bender

Euphrosyne Gouzoulis-Mayfrank

4

0 references

6

object named as

Euphrosyne Gouzoulis-Mayfrank

1 reference

11 February 2018

author name string

Daniel Wagner

2

1 reference

11 February 2018

Philip Koester

3

1 reference

11 February 2018

Christoph Kabbasch

5

1 reference

11 February 2018

publication date

23 September 2012

1 reference

11 February 2018

number of pages

12

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

11 February 2018

volume

225

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

923-934

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-012-2873-z

exact match

0 references

cites work

Altered parahippocampal functioning in cannabis users is related to the frequency of use.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Deficits of long-term memory in ecstasy users are related to cognitive complexity of the task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Abnormal brain activity in prefrontal brain regions in abstinent marijuana users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Persistent cerebrovascular effects of MDMA and acute responses to the drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Effects of frequent cannabis use on hippocampal activity during an associative memory task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

MDMA use and neurocognition: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Precentral gyrus discrepancy in electronic versions of the Talairach atlas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Validation of self-reported cannabis use by urine analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Functional MRI study of working memory in MDMA users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Deficits in learning and memory: parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Ecstasy and new patterns of drug use: a normal population study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

The Raven's progressive matrices: change and stability over culture and time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Learning and memory deficits in ecstasy users and their neural correlates during a face-learning task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

MDMA-evoked changes in cerebral blood flow in living porcine brain: correlation with hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Hair concentrations and self-reported abuse history of 20 amphetamine and ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

The neuropsychology of ecstasy (MDMA) use: a quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2873-Z

Hemodynamic response changes in cerebrovascular disease: implications for functional MR imaging

21 January 2018

1 reference

12 December 2020

Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery

1 reference

12 December 2020

Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations

1 reference

12 December 2020

Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines

1 reference

12 December 2020

Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")

1 reference

12 December 2020

Drug use and drinking among students in 36 countries.

1 reference

12 December 2020

10.1007/S00213-012-2873-Z

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018